Pharmacologic characterization of the human 5-hydroxytryptamine2B receptor: Evidence for species differences

Journal of Pharmacology and Experimental Therapeutics

Volumn 276, Issue 2, 1996, Pages 720-727

  Wainscott, David B ^a   Lucaites, Virginia L ^a   Kursar, Jonathan D ^a   Baez, Melvyn ^a   Nelson, David L ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SEROTONIN RECEPTOR;

ANIMAL; ARTICLE; DRUG EFFECT; HAMSTER; HUMAN; METABOLISM; RADIOASSAY; RAT; SPECIES DIFFERENCE; SYRIAN HAMSTER;

ANIMALS; CRICETINAE; HUMANS; MESOCRICETUS; RADIOLIGAND ASSAY; RATS; RECEPTORS, SEROTONIN; SPECIES SPECIFICITY;

EID: 0030087741     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. 1Dβ receptor. Mol Pharmacol. 41: 1-7, 1992.
2. 1C receptor. Mol. Pharmacol. 38: 31-37, 1990.
3. 2C receptors. Br. J. Pharmacol. 115: 622-628, 1995.
4. BRADFORD, M. M.: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254, 1976.
5. 50) of an enzymatic reaction. Biochem. Pharmacol. 22: 3099-3108, 1973.
6. 1D receptors. FEBS Lett. 352: 393-399, 1994.
7. CLINESCHMIDT, B. V., REISS, D. R., PETTIBONE, D. J. AND ROBINSON, J. L.: Characterization of 5-hydroxytryptamine receptors in rat stomach fundus. J. Pharmacol. Exp. Ther. 235: 696-708, 1985.
8. COHEN, M. L.: 5-Hydroxytryptamine and non-vascular smooth muscle contraction and relaxation. In The Peripheral Actions of 5-Hydroxytryptamine, ed. by J. R. Fozard, pp. 201-219, Oxford University Press, Oxford, 1989.
9. FOGUET, M., HOYER, D., PARDO, L. A., PAREKH, A., KLUXEN, F. W., KALKMAN, H O., STÜHMER, W. AND LUBBERT, H.: Cloning and functional characterization of the rat stomach fundus serotonin receptor. EMBO J. 11: 3481-3487, 1992.
10. GUARDIOLA-LEMAITRE, B.: Development of melatonin analogs. In Advances in Pineal Research: Volume 5, ed. by J. Arendt and P. Pévet, pp. 351-363, John Libbey & Co., Ltd., London, 1991.
11. 1D-like pharmacological specificity. Biochem. Biophys. Res. Commun. 184: 752-759, 1992.
12. HIBERT, M. F., TRUMPP-KALLMEYER, S., BRUINVELS, A. AND HOFLACK, J.: Three-dimensional models of neurotransmitter G-binding protein-coupled receptors. Mol. Pharmacol. 40: 8-15, 1991.
13. HOYER, D., CLARKE, D. E., FOZARD, J. R., HARTIG, P. R., MARTIN, G. R., MYLECHARANE, E. J., SAXENA, P. R. AND HUMPHREY, P. P. A.: International union of pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev. 46: 157-203, 1994.
14. 1B receptor. J. Biol. Chem. 267: 5735-5738, 1992.
15. 2 receptor. Eur. J. Pharmacol. 239: 111-118, 1993.
16. JOHNSON, M. P., LONCHARICH, R. J., BAEZ, M. AND NELSON, D. L.: Species variations in transmembrane region V of the 5-hydroxytryptamine type 2A receptor alter the structure-activity relationship of certain ergolines and tryptamines. Mol. Pharmacol 45: 277-286, 1994.
17. 2B receptor. Mol. Pharmacol. 46: 227-234, 1994.
18. 2F) from rat stomach fundus. Mol. Pharmacol. 42: 549-557, 1992.
19. 2-like receptor. Expression in brain, heart and intestine. FEBS Lett. 312: 203-207, 1992.
20. 355Asn site directed mutagenesis. Biochem. Pharmacol. 44: 1917-1920, 1992.
21. 2 receptor: Structurally specific differentiation by ergolines and tryptamines. J Pharmacol. Exp. Ther. 265: 1272-1279, 1993.
22. 1B receptors. Nature (Lond.) 360: 161-163, 1992.
23. 1B receptors. J. Neurochem. 60: 380-383, 1993.
24. 2B serotonin receptor. FEBS Lett. 342: 85-90, 1994.
25. VANE, J. R.: A sensitive method for the assay of 5-hydroxytryptamine. Br. J. Pharmacol. 12: 344-349, 1957.
26. VAN NUETEN, J. M., LEYSEN, J. E., VANHOUTTE, P. M. AND JANSSEN, P. A. J.: Serotonergic responses in vascular and non-vascular tissues. Arch. Int. Pharmacodyn. Ther. 256: 331-334, 1982.
27. 2F receptor. Mol. Pharmacol. 43: 419-426, 1993.